Meeting
2022 ASCO Annual Meeting
Survival outcomes in patients with chronic lymphocytic leukemia treated at academic centers.
Authors
Victoria Vardell
University of Utah, Salt Lake City, UT
Victoria Vardell , Daniel Arthur Ermann , Harsh Shah , Lindsey Fitzgerald , Boyu Hu , Deborah Marie Stephens
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Track
Hematologic Malignancies
Sub Track
Chronic Lymphocytic Leukemia (CLL) and Hairy Cell
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 7544)
DOI
10.1200/JCO.2022.40.16_suppl.7544
Abstract #
7544
Poster Bd #
197
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Concurrent and sequential chemoradiation therapy are associated with improved survival among unresected stage III non-small cell lung cancer patients in the United States.
First Author: Zhiyuan Zheng
Poster
2015 ASCO Annual Meeting
Overall survival in patients with Hodgkin lymphoma: Disparities by insurance status.
First Author: Rahul Parikh
Poster
2024 ASCO Annual Meeting
Treatment outcomes of brain metastasis from primary renal cell carcinoma in United States: A National Cancer Database analysis.
First Author: Vivek Podder
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Disparities in surgical outcomes and survival based on insurance status among patients with fibrolamellar hepatocellular carcinoma: A national perspective.
First Author: Alec Czaplicki